The FDA has refused to review Moderna's application to sell a new flu shot, the latest move by the Trump administration against vaccines
ModernaModerna(US:MRNA) WSJ·2026-02-11 00:14

The company said the agency wouldn't review its application on the grounds that the study testing the shot wasn't sufficient. ...

The FDA has refused to review Moderna's application to sell a new flu shot, the latest move by the Trump administration against vaccines - Reportify